Keymed Biosciences Inc. (HKG:2162)
52.40
+4.40 (9.17%)
Mar 6, 2026, 4:08 PM HKT
43.17% (1Y)
| Market Cap | 15.44B +69.7% |
| Revenue (ttm) | 955.73M +968.2% |
| Net Income | -281.99M |
| EPS | -1.07 |
| Shares Out | 294.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,403,000 |
| Average Volume | 1,401,131 |
| Open | 47.94 |
| Previous Close | 48.00 |
| Day's Range | 47.64 - 52.65 |
| 52-Week Range | 33.30 - 80.00 |
| Beta | -0.10 |
| RSI | 47.94 |
| Earnings Date | Mar 27, 2026 |